- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01613625
Interest Of Renal Elastography In Children As A Diagnostic Tool Of Renal Fibrosis: Confrontation To Histological Features Of Renal Biopsies
May 24, 2023 updated by: Assistance Publique Hopitaux De Marseille
Elastography is a emerging imaging technique that has demonstrated high reliability in the assessment of tissues stiffness and quantification of fibrosis particularly in adult's livers.
This ultrasound exploration has no secondary effects.
There is no study published in the pediatric population concerning the role of ultrasound elastrography in kidney.
The aim of this study is to look for a correlation between the elastography's results and the kidney fibrosis on children who have to undergo a renal biopsy.
Elastography may play a potential diagnostic and/or prognostic role in the management of these patients which would limit invasive biopsy procedures.
Study Overview
Study Type
Interventional
Enrollment (Actual)
106
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Marseille, France, 13354
- Assistance Publique Hopitaux de Marseille
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Male children or feminine from 5 to 18 years old to whom is indicated a renal biopsy by the néphrologue paediatrician whatever is the initial pathology, whatever are one or several current or previous treatments and whatever is their associated comorbidity
Exclusion Criteria:
- Children of less than 5 years old or more than 18 years
- Children for whom a draining renal biopsy is not or more indicated by néphrologues
- Refusal or withdrawal of the consent lit by the holders of the exercise of the parental authority or by the child if he is capable of receiving the information
- Contraindication in the realization of a draining renal biopsy (current infection, disorder of the coagulation.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Elastography
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the elastography
Time Frame: 30 months
|
to study a link enters the elasticity of the kidney estimated by the élastographie and the classification of the renal fibrosis estimated and quantified from the histology by draining renal biopsy.
|
30 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The dosage of the créatininémie
Time Frame: 30 months
|
30 months
|
the debit of filtration glomérulaire at the child
Time Frame: 30 MONTHS
|
30 MONTHS
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: alix RUOCCO, Assistance Publique Hopitaux de Marseille
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 4, 2011
Primary Completion (Actual)
October 13, 2015
Study Completion (Actual)
May 24, 2023
Study Registration Dates
First Submitted
January 26, 2011
First Submitted That Met QC Criteria
June 5, 2012
First Posted (Estimated)
June 7, 2012
Study Record Updates
Last Update Posted (Actual)
May 25, 2023
Last Update Submitted That Met QC Criteria
May 24, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2010-A00950-39
- 2010-10 (Other Identifier: AP HM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on RENAL FIBROSIS
-
Asan Medical CenterUlsan University Hospital; Korea University Anam Hospital; Inje University; Hallym...UnknownKidney Transplant Failure | Renal FibrosisKorea, Republic of
-
Hospices Civils de LyonUnknownRenal TransplantFrance
-
Nantes University HospitalCompletedRenal TransplantFrance
-
Patrick SchjelderupAarhus University HospitalNot yet recruitingKidney Transplantation | Living Donors | Senescence | Renal Fibrosis | Multiparametric Magnetic Resonance Imaging
-
Instituto Nacional de Cardiologia Ignacio ChavezCompletedEnd Stage Renal DiseaseMexico
-
Novartis PharmaceuticalsCompleted
-
Icahn School of Medicine at Mount SinaiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Weill...Enrolling by invitation
-
Leiden University Medical CenterUnknownFibrosis | Renal Transplant RejectionNetherlands
-
Moriel VandsburgerTerminatedMyocardial Fibrosis | Healthy | Chronic Kidney DiseaseUnited States
-
Nanjing Medical UniversityUnknown
Clinical Trials on Elastography
-
Istanbul UniversityCompletedAdenomyosis | Elastography | Transvaginal Ultrasound | Fibroid UterusTurkey
-
University Hospital, Basel, SwitzerlandActive, not recruiting
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Assiut UniversityNot yet recruitingSalivary Gland Diseases
-
National Taiwan University HospitalCompletedDonor Site Complication | Muscle; IschemicTaiwan
-
Abdelrahim ElsherbinyCompleted
-
National Taiwan University HospitalRecruiting